Intra-Cellular Therapies News

Intra-Cellular Therapies | ARS: Annual Report to Security Holders

Apr 29 16:53 ET

Intra-Cellular Therapies | DEFA14A: Others

Apr 29 16:52 ET

Intra-Cellular Therapies | DEF 14A: Definitive information statements

Apr 29 16:14 ET

Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon

Apr 25 17:12 ET

Intra-Cellular Therapies | 8-K: Current report

Apr 24 16:24 ET

Intra-Cellular Therapies | 8-K: Current report

Apr 18 17:28 ET

Intra-Cellular Therapies | 424B5: Prospectus

Apr 18 17:27 ET

Intra-Cellular Therapies | 8-K: Current report

Apr 16 16:46 ET

Intra-Cellular Therapies | 424B5: Prospectus

Apr 16 16:41 ET

Intra-Cellular Therapies | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Apr 16 16:07 ET

Intra-Cellular Therapies | 8-K: Current report

Apr 16 07:14 ET

Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director VAN NOSTRAND ROBERT L

Apr 2 16:21 ET

Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B

Apr 2 16:21 ET

Intra-Cellular Therapies | 8-K: Current report

Apr 1 17:20 ET

Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B

Mar 22 16:15 ET

Intra-Cellular Therapies | 8-K: Current report

Mar 19 08:46 ET

Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon

Mar 11 20:38 ET

Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Hineline Lawrence J.

Mar 11 20:38 ET

Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Halstead Michael

Mar 11 20:33 ET

Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Neumann Mark

Mar 11 20:33 ET